Skip to content

Outlook Quality of Life Intervention

Outlook: An Intervention to Improve Quality of Life in Serious Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00784095
Enrollment
36
Registered
2008-11-03
Start date
2008-12-31
Completion date
2009-05-31
Last updated
2016-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure

Keywords

quality of life

Brief summary

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Detailed description

This is a pilot randomized control trial to evaluate the feasibility of the Outlook intervention. 36 veterans with advanced cancer, congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD) will be randomly assigned to one of three intervention groups and complete a brief battery of pre-test measures. Subjects in the first group (treatment) will meet with a facilitator three times for a period of 45 min-1 hour. In the first session, subjects will be asked to discuss issues related to life review. In the second session, participants will be asked to speak in more depth about issues such as regret, forgiveness and things left undone, In the final session, subjects will focus on heritage and legacy. The subjects in the second group (attention control) will meet with a facilitator three times for a period of 45 min- 1 hour and listen to a non-guided relaxation compact disk (CD). The third group of participants (true control) will be exposed to no intervention or attention control. One week and two weeks later, participants in all groups will receive post-test measures administered by a blinded interviewer.

Interventions

OTHERLife completion and preparation

Subjects will discuss life review, issues of forgiveness and heritage and legacy.

OTHERAttention Control

Subjects will listen to a non-guided relaxation CD.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with advanced cancer, CHF or COPD.

Exclusion criteria

Cognitive impairment, inability to speak, non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life - PreparationBaseline, 6 and 8 week follow upQuality Of Life At The End Of Life (the QUAL-E 2009) is a 31 item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 4-item preparation sub-scale is a primary outcomes measure with each item scaled from 1 to 5 with a minimum of 5, maximum of 20 score with higher scores indicating better preparation.
QUAL-E Completion Sub-scaleBaseline, 6 and 8 week follow upA sub-scale of the QUAL-E quality of life at the end of life measures. The scale range was 5-35 with higher scores indicating more positive sense of completion.

Secondary

MeasureTime frameDescription
Functional Status ADLBaseline, 6 and 8 week follow upsRosow-Breslau Activities of Daily Living scale range 17-51 with higher scores indicating greater ability.
Center for Epidemiology Studies - Depression Scale (CES-D)Baseline, 6 and 8 week follow upCenter for Epidemiology Studies - Depression Scale (CES-D) is a 10-item measure of depression. Items are rated on a 4 point likert scale with total scores ranging from 0-30. Higher scores indicate greater depressive symptoms.
POMS Anxiety Sub-scaleBaseline, 6 and 8 week follow upsThe anxiety sub-scale from the modified Brief Profile of Mood States (POMS) is a 5-item measure of psychological distress.Items are on a 5-point likert scale with scoring ranging from 5-25. Higher scores indicate greater anxiety.

Countries

United States

Participant flow

Participants by arm

ArmCount
Preparation and Completion
Subjects in the first group (treatment)will meet with the facilitator three times for a period of forty-five minutes to one our. In the first session, subjects will be asked to discuss issues related to life review. In session two, participants will speak about issues of regret and forgiveness. In the final session, subjects will focus on heritage and legacy. Life completion and preparation: Subjects will discuss life review, issues of forgiveness and heritage and legacy.
12
Attention Control
The subjects in the second group (attention control) will meet with a facilitator three times for 45 minutes and listen to a non-guided relaxation CD. Attention Control: Subjects will listen to a non-guided relaxation CD.
12
True Control
Subjects in the third group (true control) will be exposed to no intervention or attention control.
12
Total36

Baseline characteristics

CharacteristicPreparation and CompletionTotalTrue ControlAttention Control
Age, Continuous64 years
STANDARD_DEVIATION 10
67 years
STANDARD_DEVIATION 11
69 years
STANDARD_DEVIATION 14
68 years
STANDARD_DEVIATION 10
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants14 Participants4 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants5 Participants3 Participants2 Participants
Race (NIH/OMB)
White
7 Participants17 Participants5 Participants5 Participants
Region of Enrollment
United States
12 participants36 participants12 participants12 participants
Sex: Female, Male
Female
0 Participants1 Participants0 Participants1 Participants
Sex: Female, Male
Male
12 Participants35 Participants12 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 120 / 120 / 12
serious
Total, serious adverse events
0 / 121 / 120 / 12

Outcome results

Primary

QUAL-E Completion Sub-scale

A sub-scale of the QUAL-E quality of life at the end of life measures. The scale range was 5-35 with higher scores indicating more positive sense of completion.

Time frame: Baseline, 6 and 8 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
Preparation and CompletionQUAL-E Completion Sub-scale6 week follow up22.6 units on a scaleStandard Deviation 5.6
Preparation and CompletionQUAL-E Completion Sub-scaleBaseline22.4 units on a scaleStandard Deviation 6.5
Preparation and CompletionQUAL-E Completion Sub-scale8 week follow up23.4 units on a scaleStandard Deviation 5.6
Attention ControlQUAL-E Completion Sub-scale6 week follow up25.3 units on a scaleStandard Deviation 5.2
Attention ControlQUAL-E Completion Sub-scaleBaseline24.5 units on a scaleStandard Deviation 5.2
Attention ControlQUAL-E Completion Sub-scale8 week follow up24.1 units on a scaleStandard Deviation 5.9
True ControlQUAL-E Completion Sub-scaleBaseline22.5 units on a scaleStandard Deviation 6.9
True ControlQUAL-E Completion Sub-scale8 week follow up24.4 units on a scaleStandard Deviation 7.7
True ControlQUAL-E Completion Sub-scale6 week follow up23.1 units on a scaleStandard Deviation 6.1
Comparison: Intervention (Preparation and Completion) versus True Control at 8 weeks95% CI: [-4.8, 3.7]
Comparison: Intervention (Preparation and Completion) versus Attention Control at 8 weeks.95% CI: [-1.9, 6.7]
Primary

Quality of Life - Preparation

Quality Of Life At The End Of Life (the QUAL-E 2009) is a 31 item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 4-item preparation sub-scale is a primary outcomes measure with each item scaled from 1 to 5 with a minimum of 5, maximum of 20 score with higher scores indicating better preparation.

Time frame: Baseline, 6 and 8 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
Preparation and CompletionQuality of Life - Preparation6 week follow up15.2 units on a scaleStandard Deviation 3.8
Preparation and CompletionQuality of Life - PreparationBaseline14.4 units on a scaleStandard Deviation 3.9
Preparation and CompletionQuality of Life - Preparation8 week follow up16.3 units on a scaleStandard Deviation 2.7
Attention ControlQuality of Life - Preparation6 week follow up14.8 units on a scaleStandard Deviation 5.1
Attention ControlQuality of Life - PreparationBaseline16.0 units on a scaleStandard Deviation 3.7
Attention ControlQuality of Life - Preparation8 week follow up16.1 units on a scaleStandard Deviation 4.6
True ControlQuality of Life - PreparationBaseline15.4 units on a scaleStandard Deviation 4.4
True ControlQuality of Life - Preparation8 week follow up14.5 units on a scaleStandard Deviation 4.4
True ControlQuality of Life - Preparation6 week follow up14.5 units on a scaleStandard Deviation 3.9
Comparison: Intervention (Preparation and Completion) versus True Control at 8 weeksp-value: 0.04795% CI: [0.04, 5.7]Mixed Models Analysis
Comparison: Intervention (Preparation and Completion) versus Attention Control at 8 weeks95% CI: [-1.1, 4.7]
Secondary

Center for Epidemiology Studies - Depression Scale (CES-D)

Center for Epidemiology Studies - Depression Scale (CES-D) is a 10-item measure of depression. Items are rated on a 4 point likert scale with total scores ranging from 0-30. Higher scores indicate greater depressive symptoms.

Time frame: Baseline, 6 and 8 week follow up

ArmMeasureGroupValue (MEAN)Dispersion
Preparation and CompletionCenter for Epidemiology Studies - Depression Scale (CES-D)6 week follow up12.4 units on a scaleStandard Deviation 5.4
Preparation and CompletionCenter for Epidemiology Studies - Depression Scale (CES-D)Baseline12.0 units on a scaleStandard Deviation 5
Preparation and CompletionCenter for Epidemiology Studies - Depression Scale (CES-D)8 week follow up9.4 units on a scaleStandard Deviation 4.2
Attention ControlCenter for Epidemiology Studies - Depression Scale (CES-D)6 week follow up12.6 units on a scaleStandard Deviation 7.7
Attention ControlCenter for Epidemiology Studies - Depression Scale (CES-D)Baseline12.0 units on a scaleStandard Deviation 8.3
Attention ControlCenter for Epidemiology Studies - Depression Scale (CES-D)8 week follow up12.5 units on a scaleStandard Deviation 8.9
True ControlCenter for Epidemiology Studies - Depression Scale (CES-D)Baseline13.4 units on a scaleStandard Deviation 6.6
True ControlCenter for Epidemiology Studies - Depression Scale (CES-D)8 week follow up12.1 units on a scaleStandard Deviation 5.9
True ControlCenter for Epidemiology Studies - Depression Scale (CES-D)6 week follow up12.3 units on a scaleStandard Deviation 6.8
Comparison: Intervention (Preparation and Completion) versus True Control at 8 weeks95% CI: [-6.2, 2.9]
Comparison: Intervention (Preparation and Completion) versus Attention Control at 8 weeks95% CI: [-8.2, 1]
Secondary

Functional Status ADL

Rosow-Breslau Activities of Daily Living scale range 17-51 with higher scores indicating greater ability.

Time frame: Baseline, 6 and 8 week follow ups

ArmMeasureGroupValue (MEAN)Dispersion
Preparation and CompletionFunctional Status ADL8 week follow up23.1 units on a scaleStandard Deviation 5.3
Preparation and CompletionFunctional Status ADL6 week follow up23 units on a scaleStandard Deviation 5.7
Preparation and CompletionFunctional Status ADLBaseline22.3 units on a scaleStandard Deviation 4.4
Attention ControlFunctional Status ADL8 week follow up21.8 units on a scaleStandard Deviation 4
Attention ControlFunctional Status ADLBaseline21.0 units on a scaleStandard Deviation 2.3
Attention ControlFunctional Status ADL6 week follow up24 units on a scaleStandard Deviation 8.1
True ControlFunctional Status ADL8 week follow up29.8 units on a scaleStandard Deviation 8
True ControlFunctional Status ADL6 week follow up30.6 units on a scaleStandard Deviation 8.2
True ControlFunctional Status ADLBaseline29.7 units on a scaleStandard Deviation 6.4
Comparison: Intervention (Preparation and Completion) versus True Control at 8 weeks95% CI: [-3.2, 5.6]
Comparison: Intervention (Preparation and Completion) versus Attention Control at 8 weeks95% CI: [-5.6, 3.3]
Secondary

POMS Anxiety Sub-scale

The anxiety sub-scale from the modified Brief Profile of Mood States (POMS) is a 5-item measure of psychological distress.Items are on a 5-point likert scale with scoring ranging from 5-25. Higher scores indicate greater anxiety.

Time frame: Baseline, 6 and 8 week follow ups

ArmMeasureGroupValue (MEAN)Dispersion
Preparation and CompletionPOMS Anxiety Sub-scale8 week follow up4.6 units on a scaleStandard Deviation 3.3
Preparation and CompletionPOMS Anxiety Sub-scaleBaseline5.0 units on a scaleStandard Deviation 5.5
Preparation and CompletionPOMS Anxiety Sub-scale6 week follow up5.1 units on a scaleStandard Deviation 4.9
Attention ControlPOMS Anxiety Sub-scale8 week follow up4.8 units on a scaleStandard Deviation 5.4
Attention ControlPOMS Anxiety Sub-scaleBaseline4.1 units on a scaleStandard Deviation 4.1
Attention ControlPOMS Anxiety Sub-scale6 week follow up5.0 units on a scaleStandard Deviation 4
True ControlPOMS Anxiety Sub-scale8 week follow up5.3 units on a scaleStandard Deviation 4.2
True ControlPOMS Anxiety Sub-scaleBaseline5.3 units on a scaleStandard Deviation 4.4
True ControlPOMS Anxiety Sub-scale6 week follow up5.9 units on a scaleStandard Deviation 4.4
Comparison: Intervention (Preparation and Completion) versus True Control at 8 weeks95% CI: [-4.5, 3.4]
Comparison: Intervention versus Attention Control at 8 weeks.95% CI: [-5.1, 3]

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026